Intermolecular insights into allosteric inhibition of histone lysine-specific demethylase 1

Histone lysine-specific demethylase 1 (LSD1) has become a potential anticancer target for the novel drug discovery. Recent reports have shown that SP2509 and its derivatives strongly inhibit LSD1 as allosteric inhibitors. However, the binding mechanism of these allosteric inhibitors in the allosteri...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta. General subjects Vol. 1865; no. 11; p. 129990
Main Authors Zhang, Xiangyu, Sun, Yixiang, Zhang, Ziheng, Wang, Hanxun, Wang, Jian, Zhao, Dongmei
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.11.2021
Subjects
Online AccessGet full text
ISSN0304-4165
1872-8006
1872-8006
DOI10.1016/j.bbagen.2021.129990

Cover

Abstract Histone lysine-specific demethylase 1 (LSD1) has become a potential anticancer target for the novel drug discovery. Recent reports have shown that SP2509 and its derivatives strongly inhibit LSD1 as allosteric inhibitors. However, the binding mechanism of these allosteric inhibitors in the allosteric site of LSD1 is not known yet. The stability and binding mechanism of allosteric inhibitors in the binding site of LSD1 were evaluated by molecular docking, ligand-based pharmacophore, molecular dynamics (MD) simulations, molecular mechanics generalized born surface area (MM/GBSA) analysis, quantum mechanics/molecular mechanics (QM/MM) calculation and Hirshfeld surface analysis. The conformational geometry and the intermolecular interactions of allosteric inhibitors showed high binding affinity towards allosteric site of LSD1 with the neighboring amino acids (Gly358, Cys360, Leu362, Asp375 and Glu379). Meanwhile, MD simulations and MM/GBSA analysis were performed on selected allosteric inhibitors in complex with LSD1 protein, which confirmed the high stability and binding affinity of these inhibitors in the allosteric site of LSD1. The simulation results revealed the crucial factors accounting for allosteric inhibitors of LSD1, including different protein–ligand interactions, the positions and conformations of key residues, and the ligands flexibilities. Meanwhile, a halogen bond interaction between chlorine atom of ligand and key residues Trp531 and His532 was recurrent in our analysis confirming its importance. Overall, our research analyzed in depth the binding modes of allosteric inhibitors with LSD1 and could provide useful information for the design of novel allosteric inhibitors. [Display omitted] •The stability and binding mechanism of allosteric inhibitors in the binding site of LSD1 were estimated by molecular docking and pharmacophore.•Based on the QM/MM optimization, intermolecular interactions of selected complexes were analyzed by hirshfeld surfaces.•An interaction model inside the LSD1 allosteric site was proposed to provide guidance for designing LSD1 inhibitors.
AbstractList Histone lysine-specific demethylase 1 (LSD1) has become a potential anticancer target for the novel drug discovery. Recent reports have shown that SP2509 and its derivatives strongly inhibit LSD1 as allosteric inhibitors. However, the binding mechanism of these allosteric inhibitors in the allosteric site of LSD1 is not known yet.BACKGROUNDHistone lysine-specific demethylase 1 (LSD1) has become a potential anticancer target for the novel drug discovery. Recent reports have shown that SP2509 and its derivatives strongly inhibit LSD1 as allosteric inhibitors. However, the binding mechanism of these allosteric inhibitors in the allosteric site of LSD1 is not known yet.The stability and binding mechanism of allosteric inhibitors in the binding site of LSD1 were evaluated by molecular docking, ligand-based pharmacophore, molecular dynamics (MD) simulations, molecular mechanics generalized born surface area (MM/GBSA) analysis, quantum mechanics/molecular mechanics (QM/MM) calculation and Hirshfeld surface analysis.METHODSThe stability and binding mechanism of allosteric inhibitors in the binding site of LSD1 were evaluated by molecular docking, ligand-based pharmacophore, molecular dynamics (MD) simulations, molecular mechanics generalized born surface area (MM/GBSA) analysis, quantum mechanics/molecular mechanics (QM/MM) calculation and Hirshfeld surface analysis.The conformational geometry and the intermolecular interactions of allosteric inhibitors showed high binding affinity towards allosteric site of LSD1 with the neighboring amino acids (Gly358, Cys360, Leu362, Asp375 and Glu379). Meanwhile, MD simulations and MM/GBSA analysis were performed on selected allosteric inhibitors in complex with LSD1 protein, which confirmed the high stability and binding affinity of these inhibitors in the allosteric site of LSD1.RESULTSThe conformational geometry and the intermolecular interactions of allosteric inhibitors showed high binding affinity towards allosteric site of LSD1 with the neighboring amino acids (Gly358, Cys360, Leu362, Asp375 and Glu379). Meanwhile, MD simulations and MM/GBSA analysis were performed on selected allosteric inhibitors in complex with LSD1 protein, which confirmed the high stability and binding affinity of these inhibitors in the allosteric site of LSD1.The simulation results revealed the crucial factors accounting for allosteric inhibitors of LSD1, including different protein-ligand interactions, the positions and conformations of key residues, and the ligands flexibilities. Meanwhile, a halogen bond interaction between chlorine atom of ligand and key residues Trp531 and His532 was recurrent in our analysis confirming its importance.CONCLUSIONThe simulation results revealed the crucial factors accounting for allosteric inhibitors of LSD1, including different protein-ligand interactions, the positions and conformations of key residues, and the ligands flexibilities. Meanwhile, a halogen bond interaction between chlorine atom of ligand and key residues Trp531 and His532 was recurrent in our analysis confirming its importance.Overall, our research analyzed in depth the binding modes of allosteric inhibitors with LSD1 and could provide useful information for the design of novel allosteric inhibitors.GENERAL SIGNIFICANCEOverall, our research analyzed in depth the binding modes of allosteric inhibitors with LSD1 and could provide useful information for the design of novel allosteric inhibitors.
Histone lysine-specific demethylase 1 (LSD1) has become a potential anticancer target for the novel drug discovery. Recent reports have shown that SP2509 and its derivatives strongly inhibit LSD1 as allosteric inhibitors. However, the binding mechanism of these allosteric inhibitors in the allosteric site of LSD1 is not known yet.The stability and binding mechanism of allosteric inhibitors in the binding site of LSD1 were evaluated by molecular docking, ligand-based pharmacophore, molecular dynamics (MD) simulations, molecular mechanics generalized born surface area (MM/GBSA) analysis, quantum mechanics/molecular mechanics (QM/MM) calculation and Hirshfeld surface analysis.The conformational geometry and the intermolecular interactions of allosteric inhibitors showed high binding affinity towards allosteric site of LSD1 with the neighboring amino acids (Gly358, Cys360, Leu362, Asp375 and Glu379). Meanwhile, MD simulations and MM/GBSA analysis were performed on selected allosteric inhibitors in complex with LSD1 protein, which confirmed the high stability and binding affinity of these inhibitors in the allosteric site of LSD1.The simulation results revealed the crucial factors accounting for allosteric inhibitors of LSD1, including different protein–ligand interactions, the positions and conformations of key residues, and the ligands flexibilities. Meanwhile, a halogen bond interaction between chlorine atom of ligand and key residues Trp531 and His532 was recurrent in our analysis confirming its importance.Overall, our research analyzed in depth the binding modes of allosteric inhibitors with LSD1 and could provide useful information for the design of novel allosteric inhibitors.
Histone lysine-specific demethylase 1 (LSD1) has become a potential anticancer target for the novel drug discovery. Recent reports have shown that SP2509 and its derivatives strongly inhibit LSD1 as allosteric inhibitors. However, the binding mechanism of these allosteric inhibitors in the allosteric site of LSD1 is not known yet. The stability and binding mechanism of allosteric inhibitors in the binding site of LSD1 were evaluated by molecular docking, ligand-based pharmacophore, molecular dynamics (MD) simulations, molecular mechanics generalized born surface area (MM/GBSA) analysis, quantum mechanics/molecular mechanics (QM/MM) calculation and Hirshfeld surface analysis. The conformational geometry and the intermolecular interactions of allosteric inhibitors showed high binding affinity towards allosteric site of LSD1 with the neighboring amino acids (Gly358, Cys360, Leu362, Asp375 and Glu379). Meanwhile, MD simulations and MM/GBSA analysis were performed on selected allosteric inhibitors in complex with LSD1 protein, which confirmed the high stability and binding affinity of these inhibitors in the allosteric site of LSD1. The simulation results revealed the crucial factors accounting for allosteric inhibitors of LSD1, including different protein–ligand interactions, the positions and conformations of key residues, and the ligands flexibilities. Meanwhile, a halogen bond interaction between chlorine atom of ligand and key residues Trp531 and His532 was recurrent in our analysis confirming its importance. Overall, our research analyzed in depth the binding modes of allosteric inhibitors with LSD1 and could provide useful information for the design of novel allosteric inhibitors. [Display omitted] •The stability and binding mechanism of allosteric inhibitors in the binding site of LSD1 were estimated by molecular docking and pharmacophore.•Based on the QM/MM optimization, intermolecular interactions of selected complexes were analyzed by hirshfeld surfaces.•An interaction model inside the LSD1 allosteric site was proposed to provide guidance for designing LSD1 inhibitors.
ArticleNumber 129990
Author Sun, Yixiang
Wang, Jian
Zhao, Dongmei
Wang, Hanxun
Zhang, Xiangyu
Zhang, Ziheng
Author_xml – sequence: 1
  givenname: Xiangyu
  surname: Zhang
  fullname: Zhang, Xiangyu
  organization: Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, PR China
– sequence: 2
  givenname: Yixiang
  surname: Sun
  fullname: Sun, Yixiang
  organization: Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, PR China
– sequence: 3
  givenname: Ziheng
  surname: Zhang
  fullname: Zhang, Ziheng
  organization: Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, PR China
– sequence: 4
  givenname: Hanxun
  surname: Wang
  fullname: Wang, Hanxun
  organization: Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, PR China
– sequence: 5
  givenname: Jian
  surname: Wang
  fullname: Wang, Jian
  email: jianwang@syphu.edu.cn
  organization: Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, PR China
– sequence: 6
  givenname: Dongmei
  surname: Zhao
  fullname: Zhao, Dongmei
  email: dongmeiz-67@163.com
  organization: Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, PR China
BookMark eNqNkDFvFDEQhS0UJC6Bf0CxJc0etndtrymQUERIpEhpQkVh-bzj3Jx89mH7kO7f49NSUSSZZmY07z2NvktyEVMEQj4yumaUyc-79WZjnyCuOeVszbjWmr4hKzYp3k-UyguyogMd-5FJ8Y5clrKjrYQWK_LrLlbI-xTAHYPNHcaCT9ta2lBTZ0NIpd3RtX2LG6yYYpd8t8VS2w9dOBWM0JcDOPRNNcMe6vYUbIGOvSdvvQ0FPvzrV-TnzffH69v-_uHH3fW3-94NitdeUj96urEzZw6UE6OcFUgxOy28mKVTHlj7VYwaLDALapJ00qAHrrRXVg5X5NOSe8jp9xFKNXssDkKwEdKxGC4HOUo-6VdIhWSjpoM6S78sUpdTKRm8cVjtGUDNFoNh1Jzhm51Z4JszfLPAb-bxP_Mh497m00u2r4sNGq4_CNkUhxAdzJjBVTMnfD7gL1yMo4g
CitedBy_id crossref_primary_10_1016_j_ejmech_2022_114523
crossref_primary_10_1016_j_phrs_2021_105958
crossref_primary_10_1080_17460441_2022_2114451
crossref_primary_10_1021_acs_jpcb_3c06900
crossref_primary_10_1002_mco2_269
crossref_primary_10_1016_j_tips_2025_01_006
crossref_primary_10_1016_j_ejmech_2022_114714
crossref_primary_10_1016_j_freeradbiomed_2024_04_220
Cites_doi 10.1007/s11255-015-0915-2
10.1021/acs.jmedchem.7b00462
10.1038/s41585-019-0154-x
10.1016/j.molstruc.2020.128780
10.3390/molecules23071538
10.1016/j.canlet.2019.03.052
10.1038/aps.2011.145
10.1021/acs.jmedchem.5b01361
10.1016/j.ejmech.2020.112235
10.1021/jm3002845
10.1371/journal.pone.0235705
10.1021/acs.jmedchem.6b01018
10.1021/acs.jmedchem.5b01209
10.1021/acs.jmedchem.5b00037
10.1021/acsmedchemlett.9b00604
10.1038/nmeth.4067
10.1021/acs.jmedchem.6b01019
10.1039/C9SC02834J
10.1016/j.cell.2004.12.012
10.1038/leu.2014.119
10.1128/JVI.00974-20
10.1039/C9CP04353E
10.1021/jm400870h
10.1021/acsomega.8b00815
10.1021/jp408166m
10.1021/jm201048w
10.1038/s41375-019-0659-6
10.1021/bi300068r
10.1073/pnas.1719168115
10.3389/fonc.2018.00255
10.1186/s13045-019-0811-9
10.1002/anie.201608711
10.1016/j.ejmech.2012.08.010
10.1517/13543776.2016.1165209
10.1016/j.ejmech.2018.11.035
10.1021/ct900587b
10.1177/1758835920937428
10.1021/jm401002r
10.1002/cmdc.201400016
10.1016/j.bmcl.2015.06.054
10.1002/med.21350
10.1016/j.bmcl.2016.05.038
10.1016/bs.mie.2016.01.020
ContentType Journal Article
Copyright 2021 Elsevier B.V.
Copyright © 2021 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2021 Elsevier B.V.
– notice: Copyright © 2021 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
7X8
7S9
L.6
DOI 10.1016/j.bbagen.2021.129990
DatabaseName CrossRef
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE - Academic
AGRICOLA

DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1872-8006
ExternalDocumentID 10_1016_j_bbagen_2021_129990
S0304416521001495
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
23N
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
ABEFU
ABFNM
ABGSF
ABMAC
ABUDA
ABXDB
ABYKQ
ACDAQ
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEHWI
AEKER
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CS3
DOVZS
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HLW
HVGLF
HZ~
IHE
J1W
KOM
LX3
M41
MO0
N9A
O-L
O9-
OAUVE
OHT
OZT
P-8
P-9
PC.
Q38
R2-
ROL
RPZ
SBG
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SSU
SSZ
T5K
UQL
WH7
WUQ
XJT
XPP
~G-
AAHBH
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACRPL
ACVFH
ADCNI
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
BNPGV
CITATION
SSH
7X8
ACLOT
EFKBS
~HD
7S9
L.6
ID FETCH-LOGICAL-c372t-60f4f0bad21ce7c546d7e65dc95f5d6c7fe1595549eae1ae786089e93279f7a63
IEDL.DBID AIKHN
ISSN 0304-4165
1872-8006
IngestDate Sun Sep 28 02:33:04 EDT 2025
Sun Sep 28 08:40:48 EDT 2025
Tue Jul 01 00:22:15 EDT 2025
Thu Apr 24 22:54:42 EDT 2025
Fri Feb 23 02:46:07 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords LSD1/ KDM1A
SPC
HOMO
LUMO
SPE
HS
DFT
NPT
LSD2
LSD1
MD
MD simulations
SWIRM
ASM
QM
SP
AOL
Hirshfeld surface
PSA
MM
KMTs
FAD
RMSF
QM/MM
RMSD
MAO-B
Allosteric inhibitor
LBFGS
MAO-A
SASA
KDMs
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c372t-60f4f0bad21ce7c546d7e65dc95f5d6c7fe1595549eae1ae786089e93279f7a63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PQID 2561490376
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2636462896
proquest_miscellaneous_2561490376
crossref_citationtrail_10_1016_j_bbagen_2021_129990
crossref_primary_10_1016_j_bbagen_2021_129990
elsevier_sciencedirect_doi_10_1016_j_bbagen_2021_129990
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate November 2021
2021-11-00
20211101
PublicationDateYYYYMMDD 2021-11-01
PublicationDate_xml – month: 11
  year: 2021
  text: November 2021
PublicationDecade 2020
PublicationTitle Biochimica et biophysica acta. General subjects
PublicationYear 2021
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Zheng, Duan, Ma, Xu, Zi, Lv, Wang, Ye, Zhu, Mobley, Zhu, Wang, Li, Wang, Zhao, Liu (bb0015) 2013; 56
Deb, Wingelhofer, Amaral, Maiques-Diaz, Chadwick, Spencer, Williams, Leong, Maes, Somervaille (bb0145) 2019; 34
Sorna, Theisen, Stephens, Warner, Bearss, Vankayalapati, Sharma (bb0110) 2013; 56
Wu, Zhou, Yao, Wei, Feng, Deng, Song (bb0095) 2016; 59
Ota, Itoh, Kaise, Ohta, Endo, Masuda, Sowa, Sakai, Suzuki (bb0085) 2016; 55
Fiskus, Sharma, Shah, Portier, Devaraj, Liu, Iyer, Bearss, Bhalla (bb0130) 2014; 28
Ma, Zheng, Wang, Wang, Wang, Pang, Zhang, Wang, Ding, Li, Wang, Hu, Liu, Zhang, Wang, Wang, Zhao, Liu (bb0050) 2015; 58
Wen, Chen, Zeng, Zhao, Li, Liu, Zhang (bb0080) 2012; 33
Jostes, Nettersheim, Schorle (bb0140) 2019; 16
Zheng, Ma, Wang, Li, Jiang, Zhou, Shi, Wang, Zhao, Liu (bb0005) 2015; 35
Suzuki, Miyata (bb0040) 2011; 54
Sehrawat, Gao, Wang, Bankhead, McWeeney, King, Schwartzman, Urrutia, Bisson, Coleman, Joshi, Kim, Sampson, Weinmann, Kallakury, Berry, Haque, Van Den Eeden, Sharma, Bearss, Beer, Thomas, Heiser, Alumkal (bb0175) 2018; 115
Sartori, Mercurio, Amigoni, Cappa, Faga, Fattori, Legnaghi, Ciossani, Mattevi, Meroni, Moretti, Cecatiello, Pasqualato, Romussi, Thaler, Trifiro, Villa, Vultaggio, Botrugno, Dessanti, Minucci, Zagarri, Carettoni, Iuzzolino, Varasi, Vianello (bb0100) 2017; 60
Magliulo, Bernardi, Messina (bb0070) 2018; 8
Vianello, Sartori, Amigoni, Cappa, Fagá, Fattori, Legnaghi, Ciossani, Mattevi, Meroni, Moretti, Cecatiello, Pasqualato, Romussi, Thaler, Trifiró, Varasi, Botrugno, Dessanti, Minucci, Vultaggio, Zagarrí, Varasi, Mercurio (bb0105) 2017; 60
Shivakumar, Williams, Wu, Damm, Shelley, Sherman (bb0180) 2010; 6
Zhou, Li, Wang, Xiang, Luo, Yang, Yang, Zhao (bb0120) 2016; 26
Kupcewicz, Malecka, Zapadka, Krajewska, Rozalski, Budzisz (bb0220) 2016; 26
Harancher, Packard, Cowan, DeLuca, Dembowski (bb0135) 2020; 94
Decarlo, Hadden (bb0030) 2012; 56
Hazeldine, Pachaiyappan, Steinbergs, Nowotarski, Hanson, Casero, Woster (bb0045) 2012; 55
Narayanan, Redfern, Assary, Curtiss (bb0200) 2019; 10
Vianello, Botrugno, Cappa, Dal Zuffo, Dessanti, Mai, Marrocco, Mattevi, Meroni, Minucci, Stazi, Thaler, Trifiró, Valente, Villa, Varasi, Mercurio (bb0010) 2016; 59
Li, Wang, Wang, Wang, Cheng (bb0185) 2015; 2015
Soldi, Ghosh Halder, Weston, Thode, Drenner, Lewis, Kaadige, Srivastava, Daniel Ampanattu, Rodriguez Del Villar, Lang, Vankayalapati, Weissman, Trent, Hendricks, Sharma (bb0155) 2020; 15
Hayward, Cole (bb0075) 2016; 573
Mould, Alli, Bremberg, Cartic, Jordan, Geitmann, Maiques-Diaz, McGonagle, Somervaille, Spencer, Turlais, Ogilvie (bb0055) 2017; 60
Wang, Liu, Jiang, Chen, Guo, Weng (bb0090) 2015; 47
Huang, Rauscher, Nawrocki, Ran, Feig, de Groot, Grubmuller, MacKerell (bb0170) 2017; 14
Stazi, Zwergel, Valente, Mai (bb0065) 2016; 26
Parvarinezhad, Salehi (bb0215) 2020; 1222
Wang, Gao, Song, Hu, Wang, Cheng (bb0190) 2019; 21
Rodrigues-Oliveira, Ribeiro, Cervi, Correra (bb0195) 2018; 3
Peng, Zhang, Tan, Li, Zhou, Wang, Liu, Li, Cen, Yang, Zhao (bb0125) 2020; 12
Wang, He, Li, Ma, Xue, Hu, Wang, Zhang, Zhang (bb0210) 2020; 193
Ma, Yao, Zheng, Feng, Chang, Yu, Liu (bb0020) 2019; 162
Romussi, Cappa, Vianello, Brambillasca, Cera, Dal Zuffo, Fagà, Fattori, Moretti, Trifirò, Villa, Vultaggio, Cecatiello, Pasqualato, Dondio, So, Minucci, Sartori, Varasi, Mercurio (bb0035) 2020; 11
Walker, Harvey, Sen, Dessent (bb0205) 2013; 117
Niwa, Sato, Hashimoto, Matsuno, Umehara (bb0060) 2018; 23
Baron, Vellore (bb0160) 2012; 51
Li, Wang, Xu, Huang, Li, Jin, Zhao, Cheng (bb0165) 2014; 9
Shi, Lan, Matson, Mulligan, Whetstine, Cole, Casero, Shi (bb0025) 2004; 119
Parwani (bb0225) 2009; 2009
Fang, Liao, Yu (bb0150) 2019; 12
Li, Tao, Zuo, Zhou, Qian, Lin, Jie, Liu, Li, Zhang, Zhang, Cen, Yang, Zhao (bb0115) 2019; 454
Ma (10.1016/j.bbagen.2021.129990_bb0020) 2019; 162
Vianello (10.1016/j.bbagen.2021.129990_bb0105) 2017; 60
Parvarinezhad (10.1016/j.bbagen.2021.129990_bb0215) 2020; 1222
Zhou (10.1016/j.bbagen.2021.129990_bb0120) 2016; 26
Fang (10.1016/j.bbagen.2021.129990_bb0150) 2019; 12
Niwa (10.1016/j.bbagen.2021.129990_bb0060) 2018; 23
Wen (10.1016/j.bbagen.2021.129990_bb0080) 2012; 33
Narayanan (10.1016/j.bbagen.2021.129990_bb0200) 2019; 10
Baron (10.1016/j.bbagen.2021.129990_bb0160) 2012; 51
Wang (10.1016/j.bbagen.2021.129990_bb0190) 2019; 21
Walker (10.1016/j.bbagen.2021.129990_bb0205) 2013; 117
Li (10.1016/j.bbagen.2021.129990_bb0185) 2015; 2015
Wang (10.1016/j.bbagen.2021.129990_bb0090) 2015; 47
Mould (10.1016/j.bbagen.2021.129990_bb0055) 2017; 60
Li (10.1016/j.bbagen.2021.129990_bb0115) 2019; 454
Deb (10.1016/j.bbagen.2021.129990_bb0145) 2019; 34
Sorna (10.1016/j.bbagen.2021.129990_bb0110) 2013; 56
Peng (10.1016/j.bbagen.2021.129990_bb0125) 2020; 12
Zheng (10.1016/j.bbagen.2021.129990_bb0005) 2015; 35
Rodrigues-Oliveira (10.1016/j.bbagen.2021.129990_bb0195) 2018; 3
Hayward (10.1016/j.bbagen.2021.129990_bb0075) 2016; 573
Harancher (10.1016/j.bbagen.2021.129990_bb0135) 2020; 94
Decarlo (10.1016/j.bbagen.2021.129990_bb0030) 2012; 56
Wu (10.1016/j.bbagen.2021.129990_bb0095) 2016; 59
Shivakumar (10.1016/j.bbagen.2021.129990_bb0180) 2010; 6
Suzuki (10.1016/j.bbagen.2021.129990_bb0040) 2011; 54
Jostes (10.1016/j.bbagen.2021.129990_bb0140) 2019; 16
Sehrawat (10.1016/j.bbagen.2021.129990_bb0175) 2018; 115
Vianello (10.1016/j.bbagen.2021.129990_bb0010) 2016; 59
Zheng (10.1016/j.bbagen.2021.129990_bb0015) 2013; 56
Parwani (10.1016/j.bbagen.2021.129990_bb0225) 2009; 2009
Sartori (10.1016/j.bbagen.2021.129990_bb0100) 2017; 60
Stazi (10.1016/j.bbagen.2021.129990_bb0065) 2016; 26
Li (10.1016/j.bbagen.2021.129990_bb0165) 2014; 9
Romussi (10.1016/j.bbagen.2021.129990_bb0035) 2020; 11
Fiskus (10.1016/j.bbagen.2021.129990_bb0130) 2014; 28
Hazeldine (10.1016/j.bbagen.2021.129990_bb0045) 2012; 55
Huang (10.1016/j.bbagen.2021.129990_bb0170) 2017; 14
Soldi (10.1016/j.bbagen.2021.129990_bb0155) 2020; 15
Wang (10.1016/j.bbagen.2021.129990_bb0210) 2020; 193
Kupcewicz (10.1016/j.bbagen.2021.129990_bb0220) 2016; 26
Shi (10.1016/j.bbagen.2021.129990_bb0025) 2004; 119
Ma (10.1016/j.bbagen.2021.129990_bb0050) 2015; 58
Magliulo (10.1016/j.bbagen.2021.129990_bb0070) 2018; 8
Ota (10.1016/j.bbagen.2021.129990_bb0085) 2016; 55
References_xml – volume: 117
  start-page: 12590
  year: 2013
  end-page: 12600
  ident: bb0205
  article-title: Performance of M06, M06–2X, and M06-HF density functionals for conformationally flexible anionic clusters: M06 functionals perform better than B3LYP for a model system with dispersion and ionic hydrogen-bonding interactions
  publication-title: J. Phys. Chem. A
– volume: 6
  start-page: 1509
  year: 2010
  end-page: 1519
  ident: bb0180
  article-title: Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field
  publication-title: J. Chem. Theory Comput.
– volume: 58
  start-page: 1705
  year: 2015
  end-page: 1716
  ident: bb0050
  article-title: Design, synthesis, and structure-activity relationship of novel LSD1 inhibitors based on pyrimidine-thiourea hybrids as potent, orally active antitumor agents
  publication-title: J. Med. Chem.
– volume: 28
  start-page: 2155
  year: 2014
  end-page: 2164
  ident: bb0130
  article-title: Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells
  publication-title: Leukemia
– volume: 10
  start-page: 7449
  year: 2019
  end-page: 7455
  ident: bb0200
  article-title: Accurate quantum chemical energies for 133 000 organic molecules
  publication-title: Chem. Sci.
– volume: 14
  start-page: 71
  year: 2017
  end-page: 73
  ident: bb0170
  article-title: CHARMM36m: an improved force field for folded and intrinsically disordered proteins
  publication-title: Nat. Methods
– volume: 59
  start-page: 1501
  year: 2016
  end-page: 1517
  ident: bb0010
  article-title: Discovery of a novel inhibitor of histone lysine-specific demethylase 1A (KDM1A/LSD1) as orally active antitumor agent
  publication-title: J. Med. Chem.
– volume: 54
  start-page: 8236
  year: 2011
  end-page: 8250
  ident: bb0040
  article-title: Lysine demethylases inhibitors
  publication-title: J. Med. Chem.
– volume: 11
  start-page: 754
  year: 2020
  end-page: 759
  ident: bb0035
  article-title: Discovery of reversible inhibitors of KDM1A efficacious in acute myeloid leukemia models
  publication-title: ACS Med. Chem. Lett.
– volume: 454
  start-page: 179
  year: 2019
  end-page: 190
  ident: bb0115
  article-title: ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway
  publication-title: Cancer Lett.
– volume: 60
  start-page: 1693
  year: 2017
  end-page: 1715
  ident: bb0105
  publication-title: J. Med. Chem.
– volume: 47
  start-page: 485
  year: 2015
  end-page: 490
  ident: bb0090
  article-title: Relationship between LSD1 expression and E-cadherin expression in prostate cancer
  publication-title: Int. Urol. Nephrol.
– volume: 34
  start-page: 1266
  year: 2019
  end-page: 1277
  ident: bb0145
  article-title: Pre-clinical activity of combined LSD1 and mTORC1 inhibition in MLL-translocated acute myeloid leukaemia
  publication-title: Leukemia
– volume: 115
  start-page: E4179
  year: 2018
  end-page: E4188
  ident: bb0175
  article-title: LSD1 activates a lethal prostate cancer gene network independently of its demethylase function
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 573
  start-page: 261
  year: 2016
  end-page: 278
  ident: bb0075
  article-title: LSD1 histone demethylase assays and inhibition
  publication-title: Methods Enzymol.
– volume: 2015
  year: 2015
  ident: bb0185
  article-title: In silico design of human IMPDH inhibitors using pharmacophore mapping and molecular docking approaches
  publication-title: Comput. Math. Method. M.
– volume: 8
  start-page: 255
  year: 2018
  ident: bb0070
  article-title: Lysine-specific demethylase 1A as a promising target in acute myeloid leukemia
  publication-title: Front. Oncol.
– volume: 1222
  year: 2020
  ident: bb0215
  article-title: Synthesis, characterization, crystal structures, Hirshfeld surface analysis and DFT computational studies of new Schiff bases derived from phenylhydrazine
  publication-title: J. Mol. Struct.
– volume: 23
  year: 2018
  ident: bb0060
  article-title: Crystal structure of LSD1 in complex with 4-[5-(piperidin-4-ylmethoxy)-2-(p-tolyl)pyridin-3-yl]benzonitrile
  publication-title: Molecules
– volume: 33
  start-page: 109
  year: 2012
  end-page: 119
  ident: bb0080
  article-title: Triptolide induces cell-cycle arrest and apoptosis of human multiple myeloma cells in vitro via altering expression of histone demethylase LSD1 and JMJD2B
  publication-title: Acta Pharmacol. Sin.
– volume: 15
  year: 2020
  ident: bb0155
  article-title: The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer
  publication-title: Plos One
– volume: 35
  start-page: 1032
  year: 2015
  end-page: 1071
  ident: bb0005
  article-title: A systematic review of histone lysine-specific demethylase 1 and its inhibitors
  publication-title: Med. Res. Rev.
– volume: 26
  start-page: 4552
  year: 2016
  end-page: 4557
  ident: bb0120
  article-title: Synthesis and biological evaluation of novel (E)-N'-(2,3-dihydro-1H-inden-1-ylidene) benzohydrazides as potent LSD1 inhibitors
  publication-title: Bioorg. Med. Chem. Lett.
– volume: 59
  start-page: 253
  year: 2016
  end-page: 263
  ident: bb0095
  article-title: 3-(Piperidin-4-ylmethoxy)pyridine containing compounds are potent inhibitors of lysine specific demethylase 1
  publication-title: J. Med. Chem.
– volume: 193
  year: 2020
  ident: bb0210
  article-title: Carvedilol serves as a novel CYP1B1 inhibitor, a systematic drug repurposing approach through structure-based virtual screening and experimental verification
  publication-title: Eur. J. Med. Chem.
– volume: 162
  start-page: 555
  year: 2019
  end-page: 567
  ident: bb0020
  article-title: Ligand-based design, synthesis and biological evaluation of xanthine derivatives as LSD1/KDM1A inhibitors
  publication-title: Eur. J. Med. Chem.
– volume: 55
  start-page: 7378
  year: 2012
  end-page: 7391
  ident: bb0045
  article-title: Low molecular weight amidoximes that act as potent inhibitors of lysine-specific demethylase 1
  publication-title: J. Med. Chem.
– volume: 55
  start-page: 16115
  year: 2016
  end-page: 16118
  ident: bb0085
  article-title: Targeting cancer with PCPA-drug conjugates: LSD1 inhibition-triggered release of 4-hydroxytamoxifen
  publication-title: Angew. Chem. Int. Ed. Engl.
– volume: 26
  start-page: 3336
  year: 2016
  end-page: 3341
  ident: bb0220
  article-title: Quantitative relationships between structure and cytotoxic activity of flavonoid derivatives. an application of Hirshfeld surface derived descriptors
  publication-title: Bioorg. Med. Chem. Lett.
– volume: 60
  start-page: 7984
  year: 2017
  end-page: 7999
  ident: bb0055
  article-title: Development of (4-cyanophenyl)glycine derivatives as reversible inhibitors of lysine specific demethylase 1
  publication-title: J. Med. Chem.
– volume: 26
  start-page: 565
  year: 2016
  end-page: 580
  ident: bb0065
  article-title: LSD1 inhibitors: a patent review (2010–2015)
  publication-title: Expert. Opin. Ther. Pat.
– volume: 56
  start-page: 9496
  year: 2013
  end-page: 9508
  ident: bb0110
  article-title: High-throughput virtual screening identifies novel N'-(1-phenylethylidene)-benzohydrazides as potent, specific, and reversible LSD1 inhibitors
  publication-title: J. Med. Chem.
– volume: 21
  start-page: 24147
  year: 2019
  end-page: 24164
  ident: bb0190
  article-title: Molecular dynamics simulation and QM/MM calculation reveal the selectivity mechanism of type I 1/2 kinase inhibitors: the effect of intramolecular H-bonds and conformational restriction for improved selectivity
  publication-title: Phys. Chem. Chem. Phys.
– volume: 12
  start-page: 129
  year: 2019
  ident: bb0150
  article-title: LSD1/KDM1A inhibitors in clinical trials: advances and prospects
  publication-title: J. Hematol. Oncol.
– volume: 56
  start-page: 8543
  year: 2013
  end-page: 8560
  ident: bb0015
  article-title: Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration
  publication-title: J. Med. Chem.
– volume: 60
  start-page: 1673
  year: 2017
  end-page: 1692
  ident: bb0100
  article-title: Thieno[3,2-b]pyrrole-5-carboxamides as new reversible inhibitors of histone lysine demethylase KDM1A/LSD1. part 1: high-throughput screening and preliminary exploration
  publication-title: J. Med. Chem.
– volume: 94
  year: 2020
  ident: bb0135
  article-title: Antiviral properties of the LSD1 inhibitor SP-2509
  publication-title: J. Virol.
– volume: 9
  start-page: 1012
  year: 2014
  end-page: 1022
  ident: bb0165
  article-title: Computational insight into p21-activated kinase 4 inhibition: a combined ligand- and structure-based approach
  publication-title: ChemMedChem
– volume: 2009
  start-page: 93
  year: 2009
  end-page: 95
  ident: bb0225
  publication-title: Expression of Glypican 3 in Ovarian and Extragonadal Germ Cell Tumors, Yearbook of Pathology and Laboratory Medicine
– volume: 56
  start-page: 179
  year: 2012
  end-page: 194
  ident: bb0030
  article-title: Oncoepigenomics: making histone lysine methylation count
  publication-title: Eur. J. Med. Chem.
– volume: 3
  start-page: 9075
  year: 2018
  end-page: 9085
  ident: bb0195
  article-title: Evaluation of common theoretical methods for predicting infrared multiphotonic dissociation vibrational spectra of intramolecular hydrogen-bonded ions
  publication-title: ACS Omega
– volume: 119
  start-page: 941
  year: 2004
  end-page: 953
  ident: bb0025
  article-title: Histone demethylation mediated by the nuclear amine oxidase homolog LSD1
  publication-title: Cell
– volume: 16
  start-page: 245
  year: 2019
  end-page: 259
  ident: bb0140
  article-title: Epigenetic drugs and their molecular targets in testicular germ cell tumours
  publication-title: Nat. Rev. Urol.
– volume: 12
  year: 2020
  ident: bb0125
  article-title: Synergistic antitumor effect of 5-fluorouracil with the novel LSD1 inhibitor ZY0511 in colorectal cancer
  publication-title: Ther. Adv. Med. Oncol.
– volume: 51
  start-page: 3151
  year: 2012
  end-page: 3153
  ident: bb0160
  article-title: LSD1/CoREST reversible opening-closing dynamics: discovery of a nanoscale clamp for chromatin and protein binding
  publication-title: Biochemistry
– volume: 47
  start-page: 485
  year: 2015
  ident: 10.1016/j.bbagen.2021.129990_bb0090
  article-title: Relationship between LSD1 expression and E-cadherin expression in prostate cancer
  publication-title: Int. Urol. Nephrol.
  doi: 10.1007/s11255-015-0915-2
– volume: 60
  start-page: 7984
  year: 2017
  ident: 10.1016/j.bbagen.2021.129990_bb0055
  article-title: Development of (4-cyanophenyl)glycine derivatives as reversible inhibitors of lysine specific demethylase 1
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.7b00462
– volume: 16
  start-page: 245
  year: 2019
  ident: 10.1016/j.bbagen.2021.129990_bb0140
  article-title: Epigenetic drugs and their molecular targets in testicular germ cell tumours
  publication-title: Nat. Rev. Urol.
  doi: 10.1038/s41585-019-0154-x
– volume: 1222
  year: 2020
  ident: 10.1016/j.bbagen.2021.129990_bb0215
  article-title: Synthesis, characterization, crystal structures, Hirshfeld surface analysis and DFT computational studies of new Schiff bases derived from phenylhydrazine
  publication-title: J. Mol. Struct.
  doi: 10.1016/j.molstruc.2020.128780
– volume: 23
  year: 2018
  ident: 10.1016/j.bbagen.2021.129990_bb0060
  article-title: Crystal structure of LSD1 in complex with 4-[5-(piperidin-4-ylmethoxy)-2-(p-tolyl)pyridin-3-yl]benzonitrile
  publication-title: Molecules
  doi: 10.3390/molecules23071538
– volume: 454
  start-page: 179
  year: 2019
  ident: 10.1016/j.bbagen.2021.129990_bb0115
  article-title: ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2019.03.052
– volume: 33
  start-page: 109
  year: 2012
  ident: 10.1016/j.bbagen.2021.129990_bb0080
  article-title: Triptolide induces cell-cycle arrest and apoptosis of human multiple myeloma cells in vitro via altering expression of histone demethylase LSD1 and JMJD2B
  publication-title: Acta Pharmacol. Sin.
  doi: 10.1038/aps.2011.145
– volume: 59
  start-page: 253
  year: 2016
  ident: 10.1016/j.bbagen.2021.129990_bb0095
  article-title: 3-(Piperidin-4-ylmethoxy)pyridine containing compounds are potent inhibitors of lysine specific demethylase 1
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.5b01361
– volume: 193
  year: 2020
  ident: 10.1016/j.bbagen.2021.129990_bb0210
  article-title: Carvedilol serves as a novel CYP1B1 inhibitor, a systematic drug repurposing approach through structure-based virtual screening and experimental verification
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2020.112235
– volume: 55
  start-page: 7378
  year: 2012
  ident: 10.1016/j.bbagen.2021.129990_bb0045
  article-title: Low molecular weight amidoximes that act as potent inhibitors of lysine-specific demethylase 1
  publication-title: J. Med. Chem.
  doi: 10.1021/jm3002845
– volume: 15
  year: 2020
  ident: 10.1016/j.bbagen.2021.129990_bb0155
  article-title: The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer
  publication-title: Plos One
  doi: 10.1371/journal.pone.0235705
– volume: 60
  start-page: 1673
  year: 2017
  ident: 10.1016/j.bbagen.2021.129990_bb0100
  article-title: Thieno[3,2-b]pyrrole-5-carboxamides as new reversible inhibitors of histone lysine demethylase KDM1A/LSD1. part 1: high-throughput screening and preliminary exploration
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.6b01018
– volume: 59
  start-page: 1501
  year: 2016
  ident: 10.1016/j.bbagen.2021.129990_bb0010
  article-title: Discovery of a novel inhibitor of histone lysine-specific demethylase 1A (KDM1A/LSD1) as orally active antitumor agent
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.5b01209
– volume: 58
  start-page: 1705
  year: 2015
  ident: 10.1016/j.bbagen.2021.129990_bb0050
  article-title: Design, synthesis, and structure-activity relationship of novel LSD1 inhibitors based on pyrimidine-thiourea hybrids as potent, orally active antitumor agents
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.5b00037
– volume: 11
  start-page: 754
  year: 2020
  ident: 10.1016/j.bbagen.2021.129990_bb0035
  article-title: Discovery of reversible inhibitors of KDM1A efficacious in acute myeloid leukemia models
  publication-title: ACS Med. Chem. Lett.
  doi: 10.1021/acsmedchemlett.9b00604
– volume: 14
  start-page: 71
  year: 2017
  ident: 10.1016/j.bbagen.2021.129990_bb0170
  article-title: CHARMM36m: an improved force field for folded and intrinsically disordered proteins
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.4067
– volume: 60
  start-page: 1693
  year: 2017
  ident: 10.1016/j.bbagen.2021.129990_bb0105
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.6b01019
– volume: 10
  start-page: 7449
  year: 2019
  ident: 10.1016/j.bbagen.2021.129990_bb0200
  article-title: Accurate quantum chemical energies for 133 000 organic molecules
  publication-title: Chem. Sci.
  doi: 10.1039/C9SC02834J
– volume: 119
  start-page: 941
  year: 2004
  ident: 10.1016/j.bbagen.2021.129990_bb0025
  article-title: Histone demethylation mediated by the nuclear amine oxidase homolog LSD1
  publication-title: Cell
  doi: 10.1016/j.cell.2004.12.012
– volume: 28
  start-page: 2155
  year: 2014
  ident: 10.1016/j.bbagen.2021.129990_bb0130
  article-title: Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells
  publication-title: Leukemia
  doi: 10.1038/leu.2014.119
– volume: 94
  year: 2020
  ident: 10.1016/j.bbagen.2021.129990_bb0135
  article-title: Antiviral properties of the LSD1 inhibitor SP-2509
  publication-title: J. Virol.
  doi: 10.1128/JVI.00974-20
– volume: 21
  start-page: 24147
  year: 2019
  ident: 10.1016/j.bbagen.2021.129990_bb0190
  article-title: Molecular dynamics simulation and QM/MM calculation reveal the selectivity mechanism of type I 1/2 kinase inhibitors: the effect of intramolecular H-bonds and conformational restriction for improved selectivity
  publication-title: Phys. Chem. Chem. Phys.
  doi: 10.1039/C9CP04353E
– volume: 56
  start-page: 9496
  year: 2013
  ident: 10.1016/j.bbagen.2021.129990_bb0110
  article-title: High-throughput virtual screening identifies novel N'-(1-phenylethylidene)-benzohydrazides as potent, specific, and reversible LSD1 inhibitors
  publication-title: J. Med. Chem.
  doi: 10.1021/jm400870h
– volume: 3
  start-page: 9075
  year: 2018
  ident: 10.1016/j.bbagen.2021.129990_bb0195
  article-title: Evaluation of common theoretical methods for predicting infrared multiphotonic dissociation vibrational spectra of intramolecular hydrogen-bonded ions
  publication-title: ACS Omega
  doi: 10.1021/acsomega.8b00815
– volume: 117
  start-page: 12590
  year: 2013
  ident: 10.1016/j.bbagen.2021.129990_bb0205
  article-title: Performance of M06, M06–2X, and M06-HF density functionals for conformationally flexible anionic clusters: M06 functionals perform better than B3LYP for a model system with dispersion and ionic hydrogen-bonding interactions
  publication-title: J. Phys. Chem. A
  doi: 10.1021/jp408166m
– volume: 54
  start-page: 8236
  year: 2011
  ident: 10.1016/j.bbagen.2021.129990_bb0040
  article-title: Lysine demethylases inhibitors
  publication-title: J. Med. Chem.
  doi: 10.1021/jm201048w
– volume: 34
  start-page: 1266
  year: 2019
  ident: 10.1016/j.bbagen.2021.129990_bb0145
  article-title: Pre-clinical activity of combined LSD1 and mTORC1 inhibition in MLL-translocated acute myeloid leukaemia
  publication-title: Leukemia
  doi: 10.1038/s41375-019-0659-6
– volume: 51
  start-page: 3151
  year: 2012
  ident: 10.1016/j.bbagen.2021.129990_bb0160
  article-title: LSD1/CoREST reversible opening-closing dynamics: discovery of a nanoscale clamp for chromatin and protein binding
  publication-title: Biochemistry
  doi: 10.1021/bi300068r
– volume: 115
  start-page: E4179
  year: 2018
  ident: 10.1016/j.bbagen.2021.129990_bb0175
  article-title: LSD1 activates a lethal prostate cancer gene network independently of its demethylase function
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1719168115
– volume: 8
  start-page: 255
  year: 2018
  ident: 10.1016/j.bbagen.2021.129990_bb0070
  article-title: Lysine-specific demethylase 1A as a promising target in acute myeloid leukemia
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2018.00255
– volume: 12
  start-page: 129
  year: 2019
  ident: 10.1016/j.bbagen.2021.129990_bb0150
  article-title: LSD1/KDM1A inhibitors in clinical trials: advances and prospects
  publication-title: J. Hematol. Oncol.
  doi: 10.1186/s13045-019-0811-9
– volume: 55
  start-page: 16115
  year: 2016
  ident: 10.1016/j.bbagen.2021.129990_bb0085
  article-title: Targeting cancer with PCPA-drug conjugates: LSD1 inhibition-triggered release of 4-hydroxytamoxifen
  publication-title: Angew. Chem. Int. Ed. Engl.
  doi: 10.1002/anie.201608711
– volume: 56
  start-page: 179
  year: 2012
  ident: 10.1016/j.bbagen.2021.129990_bb0030
  article-title: Oncoepigenomics: making histone lysine methylation count
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2012.08.010
– volume: 2015
  year: 2015
  ident: 10.1016/j.bbagen.2021.129990_bb0185
  article-title: In silico design of human IMPDH inhibitors using pharmacophore mapping and molecular docking approaches
  publication-title: Comput. Math. Method. M.
– volume: 26
  start-page: 565
  year: 2016
  ident: 10.1016/j.bbagen.2021.129990_bb0065
  article-title: LSD1 inhibitors: a patent review (2010–2015)
  publication-title: Expert. Opin. Ther. Pat.
  doi: 10.1517/13543776.2016.1165209
– volume: 162
  start-page: 555
  year: 2019
  ident: 10.1016/j.bbagen.2021.129990_bb0020
  article-title: Ligand-based design, synthesis and biological evaluation of xanthine derivatives as LSD1/KDM1A inhibitors
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2018.11.035
– volume: 6
  start-page: 1509
  year: 2010
  ident: 10.1016/j.bbagen.2021.129990_bb0180
  article-title: Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field
  publication-title: J. Chem. Theory Comput.
  doi: 10.1021/ct900587b
– volume: 2009
  start-page: 93
  year: 2009
  ident: 10.1016/j.bbagen.2021.129990_bb0225
– volume: 12
  year: 2020
  ident: 10.1016/j.bbagen.2021.129990_bb0125
  article-title: Synergistic antitumor effect of 5-fluorouracil with the novel LSD1 inhibitor ZY0511 in colorectal cancer
  publication-title: Ther. Adv. Med. Oncol.
  doi: 10.1177/1758835920937428
– volume: 56
  start-page: 8543
  year: 2013
  ident: 10.1016/j.bbagen.2021.129990_bb0015
  article-title: Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration
  publication-title: J. Med. Chem.
  doi: 10.1021/jm401002r
– volume: 9
  start-page: 1012
  year: 2014
  ident: 10.1016/j.bbagen.2021.129990_bb0165
  article-title: Computational insight into p21-activated kinase 4 inhibition: a combined ligand- and structure-based approach
  publication-title: ChemMedChem
  doi: 10.1002/cmdc.201400016
– volume: 26
  start-page: 4552
  year: 2016
  ident: 10.1016/j.bbagen.2021.129990_bb0120
  article-title: Synthesis and biological evaluation of novel (E)-N'-(2,3-dihydro-1H-inden-1-ylidene) benzohydrazides as potent LSD1 inhibitors
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2015.06.054
– volume: 35
  start-page: 1032
  year: 2015
  ident: 10.1016/j.bbagen.2021.129990_bb0005
  article-title: A systematic review of histone lysine-specific demethylase 1 and its inhibitors
  publication-title: Med. Res. Rev.
  doi: 10.1002/med.21350
– volume: 26
  start-page: 3336
  year: 2016
  ident: 10.1016/j.bbagen.2021.129990_bb0220
  article-title: Quantitative relationships between structure and cytotoxic activity of flavonoid derivatives. an application of Hirshfeld surface derived descriptors
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2016.05.038
– volume: 573
  start-page: 261
  year: 2016
  ident: 10.1016/j.bbagen.2021.129990_bb0075
  article-title: LSD1 histone demethylase assays and inhibition
  publication-title: Methods Enzymol.
  doi: 10.1016/bs.mie.2016.01.020
SSID ssj0000595
Score 2.4038615
Snippet Histone lysine-specific demethylase 1 (LSD1) has become a potential anticancer target for the novel drug discovery. Recent reports have shown that SP2509 and...
SourceID proquest
crossref
elsevier
SourceType Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 129990
SubjectTerms Allosteric inhibitor
chlorine
drugs
geometry
Hirshfeld surface
histones
ligands
LSD1
MD simulations
molecular dynamics
pharmacology
QM/MM
quantum mechanics
surface area
Title Intermolecular insights into allosteric inhibition of histone lysine-specific demethylase 1
URI https://dx.doi.org/10.1016/j.bbagen.2021.129990
https://www.proquest.com/docview/2561490376
https://www.proquest.com/docview/2636462896
Volume 1865
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NS-UwEB_0yaIX8Wvxmwh7ja-fSXuUh_JU9KKC4CEkaYJddvvE9zx48W93Jm2VlUXBW1MSWibpzC_NzO8H8KvUOjZF4XlssohnaVJxjIoFlxXuHXRqMhlE-y4uxfgmO7vNb-dg1NfCUFpl5_tbnx68dXdn2Flz-FDXwys61EM4gfGnxfnzsJBgtC8GsHB0ej6-fHfIeRBfof6cBvQVdCHNyxj8bokINYkPMfYF5_z_CPXBV4cAdLICyx1yZEfty63CnGvW4EerJfm8BoujXrptHe7Cf76_vfItq5sp7cGneDGbMDpqJ3qE2mL7vjYhaYtNPAvcw41jxFLSOE5FmJRIxCpHOtPPiLMdizfg5uT4ejTmnYoCt6lMZlxEPvOR0VUSWydtnolKOpFXtsx9XgkrvUNIg6iidNrF2slCREXpENfJ0kst0p8waPDhm8CE99qK1FYIgjJtc-11nHoEFF6YSPhkC9Lecsp2FOOkdPFH9blkv1Vrb0X2Vq29t4C_jXpoKTa-6C_7SVH_LBWFUeCLkQf9HCqcEToa0Y2bPE1VQoSoZYTe9pM-IhVUyVuK7W-_wQ4sUastZtyFwezxye0hqpmZfZg_fIn3u7X7Ckod90I
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB7RXVVwQZRS8WyNxNXdPO3kuFoVLQX2UpCQerBsxxZBkEXscuDfM-MkVKCqSL3lYSvWOJn5HM98H8BRqXVsisLz2GQRz9Kk4hgVCy4rXDvo1GQyiPadz8T0Mvt5lV-twKSvhaG0ys73tz49eOvuyqiz5ui-rke_aFMP4QTGnxbnf4BhRqLWAxiOT06nsz8OOQ_iK9SeU4e-gi6keRmD3y0RoSbxd4x9wTn_PUK98dUhAB1vwHqHHNm4HdwnWHHNJnxstSSfNmF10ku3fYbf4T_fXa98y-pmQWvwBR4s54y22okeobZ4fl2bkLTF5p4F7uHGMWIpaRynIkxKJGKVI53pJ8TZjsVbcHn842Iy5Z2KArepTJZcRD7zkdFVElsnbZ6JSjqRV7bMfV4JK71DSIOoonTaxdrJQkRF6RDXydJLLdIvMGjw4dvAhPfaitRWCIIybXPtdZx6BBRemEj4ZAfS3nLKdhTjpHRxq_pcshvV2luRvVVr7x3gL73uW4qNd9rLflLUq1dFYRR4p-dhP4cKZ4S2RnTj5o8LlRAhahmht_1HG5EKquQtxe5_j-AbrE4vzs_U2cnsdA_W6E5b2LgPg-XDoztAhLM0X7s3-Bked_ko
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intermolecular+insights+into+allosteric+inhibition+of+histone+lysine-specific+demethylase+1&rft.jtitle=Biochimica+et+biophysica+acta.+General+subjects&rft.au=Zhang%2C+Xiangyu&rft.au=Sun%2C+Yixiang&rft.au=Zhang%2C+Ziheng&rft.au=Wang%2C+Hanxun&rft.date=2021-11-01&rft.issn=0304-4165&rft.volume=1865&rft.issue=11&rft.spage=129990&rft_id=info:doi/10.1016%2Fj.bbagen.2021.129990&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_bbagen_2021_129990
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-4165&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-4165&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-4165&client=summon